Literature DB >> 11219301

Staphylococcus aureus small colony variants: formation and clinical impact.

C von Eiff1, R A Proctor, G Peters.   

Abstract

S. aureus small-colony variants are a naturally occurring subpopulation which grow slowly and produce small colonies on routine media. They also demonstrate a number of other characteristics that are atypical for S. aureus including reduced alpha-toxin production and delayed coagulase activity. The connection of S. aureus SCVs with persistent and relapsing infections has been defined over the past decade, especially in patients with chronic osteomyelitis and in cystic fibrosis patients as demonstrated by prospective studies. While the studies with clinical isolates of SCVs suggested a link between electron transport-defective strains and persistent infections, a defined hemB mutant with the SCV phenotype provided strong additional evidence for these connections. The hemB mutant was phagocytosed by cultured endothelial cells, but did not lyse these cells, because the mutant produced very little alpha-toxin. The intracellular location may shield the SCVs from host defenses and antibiotics, thus providing one explanation for the difficulty in clearing S. aureus SCVs from host tissues.

Entities:  

Mesh:

Year:  2000        PMID: 11219301

Source DB:  PubMed          Journal:  Int J Clin Pract Suppl        ISSN: 1368-504X


  16 in total

1.  Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Authors:  O Zachrisson; P Colque-Navarro; C G Gottfries; B Regland; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

Review 2.  Current diagnostic tools for methicillin-resistant Staphylococcus aureus infections.

Authors:  Julianna Kurlenda; Mariusz Grinholc
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

3.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 4.  Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.

Authors:  Andreas Ambrosch; Simone Haefner; Edward Jude; Ralf Lobmann
Journal:  Int Wound J       Date:  2011-08-23       Impact factor: 3.315

5.  Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan.

Authors:  Joe Latimer; Sarah Forbes; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

Review 6.  [Replacement of infected knee and hip endoprostheses].

Authors:  M Militz; V Bühren
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

7.  Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.

Authors:  Brea D Duval; Anselmo Mathew; Sarah W Satola; William M Shafer
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

8.  Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa.

Authors:  Lucas R Hoffman; Eric Déziel; David A D'Argenio; François Lépine; Julia Emerson; Sharon McNamara; Ronald L Gibson; Bonnie W Ramsey; Samuel I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

9.  [Antibiotic prophylaxis in cases of closed fractures and prostheses].

Authors:  G H I M Walenkamp; J A Jacobs
Journal:  Orthopade       Date:  2004-04       Impact factor: 1.087

10.  [Classification and microbiology of osteomyelitis].

Authors:  W Zimmerli; U Flückiger
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.